Biotech
CARY, NC: CARY, NC -- (Marketwire) -- 03/02/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, March 8, 2012, to discuss its fi ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 03/02/12 -- (NASDAQ: BASI) (BASi) announced today that it plans to restructure its bioanalytical laboratory operations, a program expected to reduce operating c ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 03/02/12 -- Warnex Inc. (TSX: WNX) ("Warnex") is pleased to announce that Persistence Capital Partners LP ("PCP") has agreed to extend the maturi ...
LAVAL, QUEBEC, CANADA: LAVAL, QUEBEC, CANADA -- (Marketwire) -- 03/02/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic" or the "Company") announced today the appointment of Dr. John Moran to its ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 03/01/12 -- AVI BioPharma, Inc. (NASDAQ: AVII)Completed Dosing Through 24-Weeks in All Patients in Phase IIb DMD Study; Unblinded Results Expected by End of AprilEnrol ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 03/01/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 03/01/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment o ...
TUSTIN, CA: Data From Three Investigator Sponsored Bavituximab Clinical Trials to Be Presented ...
TURKU, FINLAND: TURKU, FINLAND -- (Marketwire) -- 03/01/12 -- Biotie today announced the completion of a Phase 1 clinical study using positron emission tomography (PET) imaging for its 5-HT6 receptor antagonist SYN ...
CONSHOHOCKEN, PA: Biodegradable Implant Being Developed to Treat Schizophrenia and Bipolar Disorder ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 02/29/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the ...
BOTHELL, WA: Company Also Presents Data on Liposomal Facilitation of Cell-to-Cell Transfer of Nucleic Acids ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 02/29/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today the execution of a securities purchase agreement with a select group of institutional and accredited ...
SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 02/29/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Barely two months into the new year, it is time to buckle up and enjoy the ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 02/29/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today that it has completed relevant milestones regarding the agreement ("Ag ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/28/12 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 02/28/12 -- Arch Biopartners Inc. ("Arch" or the "Company") (CNSX: ACH)(OTCBB: FOIFF) today announced that AUTO21 and its contributing partner ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/28/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the first q ...
